1. Home
  2. WT vs VCRE Comparison

WT vs VCRE Comparison

Compare WT & VCRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WisdomTree Inc.

WT

WisdomTree Inc.

HOLD

Current Price

$19.41

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

VCRE

Vicore Pharma Holding AB American Depositary Shares

N/A

Current Price

$11.35

Market Cap

3.3B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
WT
VCRE
Founded
1985
N/A
Country
United States
Sweden
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.3B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
WT
VCRE
Price
$19.41
$11.35
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$17.67
N/A
AVG Volume (30 Days)
3.1M
5.8K
Earning Date
05-01-2026
N/A
Dividend Yield
0.74%
N/A
EPS Growth
127.27
N/A
EPS
N/A
N/A
Revenue
$493,753,000.00
N/A
Revenue This Year
$35.04
N/A
Revenue Next Year
$8.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.43
N/A
52 Week Low
$10.69
$11.05
52 Week High
$21.23
$12.85

Technical Indicators

Market Signals
Indicator
WT
VCRE
Relative Strength Index (RSI) 54.10 16.67
Support Level $16.06 N/A
Resistance Level $19.71 $12.85
Average True Range (ATR) 0.74 0.56
MACD 0.08 -0.13
Stochastic Oscillator 46.23 13.33

Price Performance

Historical Comparison
WT
VCRE

About WT WisdomTree Inc.

WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.

About VCRE Vicore Pharma Holding AB American Depositary Shares

Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.

Share on Social Networks: